```json
{
"content": [
{
"type": "paragraph",
"content": "In Tumor Ablation, the Type segment is defined by technologies such as Radiofrequency Ablation (RFA), Microwave Ablation (MWA), and Cryoablation. RFA dominates due to its established clinical efficacy and cost-effectiveness, particularly in liver and lung cancers. MWA is gaining traction for its faster ablation zones, while Cryoablation is preferred for neurosurgical and cardiac applications due to its ability to induce controlled freezing. The Application segment is dominated by oncology (50%), driven by demand for minimally invasive cancer therapies. Pain management (20%) and non-oncological uses (15%), such as cardiac arrhythmia, further diversify the market. This Tumor Ablation and Interventional Radiology segmentation underscores the market’s reliance on therapeutic precision and evolving clinical protocols."
},
{
"type": "paragraph",
"content": "In Interventional Radiology, the Type segment includes Embolization, Angioplasty, and Percutaneous Drainage. Embolization leads with applications in uterine fibroid treatment and oncology, while Angioplasty addresses vascular blockages. Percutaneous Drainage is critical for abscess management and biliary interventions. The Application segment is driven by vascular disorders (40%), including aneurysm coiling and variceal embolization. Organ-specific interventions (30%), such as liver and kidney procedures, and diagnostic imaging (20%) further shape the market. This market taxonomy highlights the interplay between procedural complexity and unmet clinical needs, particularly in aging populations. The segment’s growth hinges on technological advancements and procedural accessibility."
}
],
"chartData": {
"segments": [
{ "name": "Oncology", "value": 50 },
{ "name": "Pain Management", "value": 20 },
{ "name": "Non-Oncological", "value": 15 },
{ "name": "Others", "value": 15 }
]
}
}
```
